Clinical trial
Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of…
NCT00476086 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00476086 |
|---|---|
| Title | Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus |
| Official title | A Phase II Study of Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Sanofi Industry Brigham and Women's Hospital Massachusetts General Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mixed Mullerian Tumors of the Uterus |
| Intervention type | Drug, Radiation |
| Interventions | Gemcitabine, Oxaliplatin, Radiation |
| Enrollment | 20 |
| Start date | Aug 1, 2006 |
| Primary completion | Mar 1, 2012 |
| Completion | Dec 1, 2015 |
| First posted | May 21, 2007 |
| Last update posted | Aug 24, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: